ArticleMetabolic brain disease2021

Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway.

Rishab Mehta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.